MENLO PARK, Calif., Feb. 1, 2024 /PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international, ...
Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology. Cortex brings together expert teams with ...
Boston Scientific (NYSE:BSX) has agreed to acquire privately held medical technology company, Cortex, Inc. Financial terms of the deal were not disclosed. The transaction is expected to close in the ...
Acquisition to complement electrophysiology portfolio with solution to advance the treatment of complex atrial fibrillation Cardiac ablation – the process of delivering energy to areas of the heart ...
Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology. MENLO PARK, Calif., Dec. 7, 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback